Humasis Co. Ltd. (KOSDAQ:205470)
South Korea
· Delayed Price · Currency is KRW 1,555.00
+2.00 (0.13%)
Jun 13, 2025, 3:30 PM KST
Humasis Revenue
Humasis had revenue of 6.16B KRW in the quarter ending March 31, 2025, with 229.81% growth. This brings the company's revenue in the last twelve months to 29.71B, up 140.71% year-over-year. In the year 2024, Humasis had annual revenue of 25.41B with 83.79% growth.
Revenue (ttm)
29.71B
Revenue Growth
+140.71%
P/S Ratio
5.92
Revenue / Employee
424.41M
Employees
70
Market Cap
175.95B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Biologics | 4,898.69B |
| Celltrion | 3,662.23B |
| ALTEOGEN | 151.65B |
| Yuhan | 2,114.76B |
| SK Biopharmaceuticals | 578.00B |
| HLB Co., Ltd. | 74.64B |
| PharmaResearch | 392.31B |
| Peptron | 4.30B |